Ngā hua rapu kaituhi :: APM

1

Phase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative study mā S Okada, Yasushi Sakata, S Matsuno, M Kurihara, Yosuke Sasaki, Yasukata Ohashi, T Taguchi

I whakaputaina 1999

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Clinical differentiation of infectious mononucleosis that is caused by Epstein-Barr virus or cytomegalovirus: A single-center case-control study in Japan mā Takamasa Ishii, Yosuke Sasaki, Tadashi Maeda, Fumiya Komatsu, Takeshi Suzuki, Yoshihisa Urita

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Oral Semaglutide Induces Loss of Body Fat Mass Without Affecting Muscle Mass in Patients With Type 2 Diabetes mā Syutaro Uchiyama, Yukiyoshi Sada, Syohei Mihara, Yosuke Sasaki, Masakatsu Sone, Yasushi Tanaka

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for meta... mā Wataru Ichikawa, Hiroyuki Uetake, Yoshinori Shirota, Hiroyuki Yamada, Takeo Takahashi, Zenro Nihei, Kenichi Sugihara, Yosuke Sasaki, Ryuichi Hirayama

I whakaputaina 2003

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer mā Wataru Ichikawa, Takehiro Takahashi, K. Suto, Tetsuro Yamashita, Zenro Nihei, Yoshinori Shirota, Jiaqi Shi, Yosuke Sasaki, Ryuichi Hirayama

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

A phase II study of eribulin in Japanese patients with heavily pretreated metastatic breast cancer mā K. Aogi, Hiroji Iwata, Norikazu Masuda, Hirofumi Mukai, Masayuki Yoshida, Yoshiaki Rai, Kenichi Taguchi, Yosuke Sasaki, Shigemitsu Takashima

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma mā Kensei Tobinai, Yukio Kobayashi, Masaru Narabayashi, Michinori Ogura, Yoshitoyo Kagami, Y Morishima, T. Ohtsu, Tomofumi Igarashi, Yosuke Sasaki, T. Kinoshita, Takashi Murate

I whakaputaina 1998

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer mā Yutaka Tokuda, Toru Watanabe, Yasushi Omuro, Masashi Ando, Noriyuki Katsumata, Akihisa Okumura, Masateru Ohta, Hirofumi Fujii, Yosuke Sasaki, Toshiro Niwa, Tomoo Tajima

I whakaputaina 1999

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitor mā Akihiro Muto, Mayumi Hori, Yosuke Sasaki, Akari Saitoh, Iho Yasuda, Tadahito Maekawa, Tomoe Uchida, Keiko Asakura, Tomonori Nakazato, Toshio Kaneda, Masahiro Kizaki, Yasuo Ikeda, Tadashi Yoshida

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies mā Masakazu Toi, Hiroji Iwata, Yasuhiro Fujiwara, Yoshiaki Ito, Shôji Nakamura, Yutaka Tokuda, Tetsuya Taguchi, Yoshiaki Rai, K. Aogi, T Arai, Junichiro Watanabe, T. Wakamatsu, Koichi Katsura, Catherine Ellis, Robert Gagnon, Kathleen Allen, Yosuke Sasaki, Shigemitsu Takashima

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese ph... mā Tomofumi Igarashi, Yukio Kobayashi, Michinori Ogura, T. Kinoshita, T. Ohtsu, Yosuke Sasaki, Y Morishima, Takashi Murate, M Kasai, Naokuni Uike, Masafumi Taniwaki, Yasuhiko Kano, Kazunori Ohnishi, Yoshihiro Matsuno, Shigeo Nakamura, Shigeki Mori, Yasuo Ohashi, Kensei Tobinai

I whakaputaina 2002

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: